MARICO Q2 : CONS NET PROFIT UP 29.2% AT RS 558 CR (YOY), DOWN 14.4% (QOQ). MIX (ON 1ST LOOK)

Revenue up 13.0% at 3,897 Cr (YOY), down 1.5% (QoQ). EBITDA up 25.1% at 762 Cr (YOY); margins 19.6% v 17.7% (YOY), 21.9% (QoQ). Caution: 75% acquisition of Skinetiq w.e.f. April 2, 2026 makes results not comparable with other periods. Post-quarter: 24.09% stake acquired in Plix, holding now 84.09% on fully diluted basis. Impact: Skinetiq acquisition and higher Plix stake limit comparability.

Marico Ltd

Open attachment

← Back to feed